Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.

Otten C, Knox J, Boulday G, Eymery M, Haniszewski M, Neuenschwander M, Radetzki S, Vogt I, Hähn K, De Luca C, Cardoso C, Hamad S, Igual Gil C, Roy P, Albiges-Rizo C, Faurobert E, von Kries JP, Campillos M, Tournier-Lasserve E, Derry WB, Abdelilah-Seyfried S

Open source

DOI: 10.15252/emmm.201809155
Published: 2018 Oct
Container: EMBO molecular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15252/emmm.201809155,
  title = {Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.},
  author = {Otten C and Knox J and Boulday G and Eymery M and Haniszewski M and Neuenschwander M and Radetzki S and Vogt I and Hähn K and De Luca C and Cardoso C and Hamad S and Igual Gil C and Roy P and Albiges-Rizo C and Faurobert E and von Kries JP and Campillos M and Tournier-Lasserve E and Derry WB and Abdelilah-Seyfried S},
  year = {2018},
  journal = {EMBO molecular medicine},
  doi = {10.15252/emmm.201809155},
  url = {https://doi.org/10.15252/emmm.201809155}
}

RIS

TY  - JOUR
TI  - Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.
AU  - Otten C
AU  - Knox J
AU  - Boulday G
AU  - Eymery M
AU  - Haniszewski M
AU  - Neuenschwander M
AU  - Radetzki S
AU  - Vogt I
AU  - Hähn K
AU  - De Luca C
AU  - Cardoso C
AU  - Hamad S
AU  - Igual Gil C
AU  - Roy P
AU  - Albiges-Rizo C
AU  - Faurobert E
AU  - von Kries JP
AU  - Campillos M
AU  - Tournier-Lasserve E
AU  - Derry WB
AU  - Abdelilah-Seyfried S
PY  - 2018
JO  - EMBO molecular medicine
DO  - 10.15252/emmm.201809155
UR  - https://doi.org/10.15252/emmm.201809155
ER  -

APA

C, O., J, K., G, B., M, E., M, H., M, N., S, R., I, V., K, H., C, D. L., C, C., S, H., C, I. G., P, R., C, A., E, F., JP, V. K., M, C., E, T., WB, D., & S, A. (2018). Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations.. EMBO molecular medicine. https://doi.org/10.15252/emmm.201809155

Source records

pubmed · retrieved 2026-09-27T10:24:34.281Z